You are here

CorMedix

CorMedix gains hard-fought approval for combo drug that reduces risk of catheter infection during dialysis

Fierce Pharma

Wed, 11/15/23 - 11:43 pm

catheter infections

It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013

TheStreet.com

Tue, 01/21/14 - 09:37 am

Intercept Pharma

Cell Therapeutics

CorMedix Granted Extension of NYSE MKT Listing

Yahoo/BusinessWire

Sat, 06/1/13 - 12:03 pm

CorMedix Reports Year End 2011 Financial Results

Mon, 03/19/12 - 10:24 pm

CorMedix (CRMD): Undervalued and Under Investor’s Radar

istockanalyst

Sat, 12/11/10 - 12:47 pm

Contrast Induced-Nephropathy